We looked at that question from two aspects. One was in pure economic terms, called volume and price, which is the growth in beneficiaries and the growth in the costs associated with beneficiaries. It's coming from both sides, so we're expecting a growth in the number of total beneficiaries over the production horizon as there's a greater number of asylum claimants who would receive coverage from the IFHP.
In terms of cost, we also expect there to be growth there, with the growth coming closer to what we see on average for expenditures per capita for Canadians, but staying slightly elevated.
